The Markets Can’t Handle a Rate Hike
Adam O’Dell: The Fed has been “talking its book” for nearly three years now.
It began in May 2013, when then-Chairman Ben Bernanke announced the Fed would begin tapering its bond-buying program.
Global markets reacted swiftly in what has since been called the “Taper Tantrum.” Ten-year Treasury rates jumped 80% higher between May and September that year.
Now, more than 30 months later, two important questions are consuming the minds of investors around the world.
First, “Will the Fed actually raise rates in December?”
Second, “What will be the impact, if rates are hiked?”
I’ll tell you straight away that I don’t have the answers to these questions. The Fed, despite its vow of transparency, always keeps the market (and analysts) guessing.
But there’s a lot to learn from how global markets typically anticipate rate hikes… and how they’re anticipating this one.
By some measures, there’s a strong argument that the stock market can’t handle a rate hike right now.
According to Guggenheim Partners’ Chief Investment Officer, Scott Minerd, the S&P 500 has typically traded higher in anticipation of a rate hike, returning an average of 23.5% during the nine months leading up to the first increase. This comes from data collected since 1980, covering six tightening periods.
Problem is… the S&P 500 is down 2% over the past nine months – a far cry from the double-digit gains it has historically mustered heading into a rate hike.
What’s more, Minerd explains that junk bonds have outperformed investment-grade bonds by an average of 4% in this nine month period.
But the credit landscape looks starkly different this go-around, as junk bonds (JNK) haveunderperformed investment-grade bonds by nearly 8%!
This gap – between historical pre-hike performance and current pre-hike performance – drives at the competing narratives surrounding the Fed’s mid-December decision.
On one hand, a rate hike theoretically suggests the U.S. economy is strong and getting stronger.
That’s an optimistic conclusion, which should prompt investors to have higher hopes for the future.
Thus, they should be willing to pay higher prices for stocks today… with expectations of increasingly positive trends tomorrow.
And those positive expectations indeed drove stock prices higher during the “anticipation” period of the last six tightening cycles. But not this time around.
This time, severe underperformance from global equity markets and junk bonds suggests investors are not optimistic about a post-hike world.
Instead, investors are downright scared of it.
This points to a conclusion that falls in the “this time is different” category. And Rodney recently put his finger on why – even though markets have pleasantly absorbed rate hikes in the past.
He wrote…
“We don’t have precedence for the Fed raising rates at this point in the business cycle (low rate of growth) at odds with other central banks, and certainly not when the world of capital is so interconnected.”
That’s a poignant statement, with three main points to break down.
For one, the Fed typically raises rates only after the U.S. economy appears to be on the verge of overheating. Today though, economic growth is nowhere close to overheating.
Secondly, most central banks around the world tend to move in the same direction – either lowering or raising rates together. Today though, U.S. monetary policy is set to go headlong against the grain of all other central banks, which are still lowering rates (many of them into negative territory).
Lastly, and now more than ever, global markets are eternally intertwined. That’s why even though there are valid arguments that the U.S. economy could handle higher rates… everyone is concerned about emerging markets imploding as soon as the Fed makes its move.
So while it’s typically a no-no to say “this time it’s different,” I believe we truly are in uncharted territory this time around.
And judging from the market’s performance over the last nine months, investors have very little confidence in the Fed’s ability to smoothly transition out of one of the most accommodative periods in financial history.
This paints a pretty bleak picture of what’s ahead. But even if the Fed has been backed into a corner, with no good solutions to the problem it created, I’m still optimistic about ourability to find opportunity in today’s wacky markets.
That’s because volatility and divergences create opportunities for active trading strategies, like ours. And the Fed’s decision next week will no doubt put many markets on the move… in different directions.
Join the conversation instantly with Facebook Comments below:
This article is brought to you courtesy of Adam O’Dell, CMT – Chief Investment Strategist, Dent Research.
You are viewing a republication of Market Daily News content. You can find full Market Daily News articles on (www.marketdailynews.com)
Source: http://marketdailynews.com/2015/12/09/the-markets-cant-handle-a-rate-hike/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
